KING LUTHER CAPITAL MANAGEMENT CORP - IMMUNOCELLULAR THERAPEUTICS ownership

IMMUNOCELLULAR THERAPEUTICS's ticker is IMUC and the CUSIP is 452536105. A total of 37 filers reported holding IMMUNOCELLULAR THERAPEUTICS in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
KING LUTHER CAPITAL MANAGEMENT CORP ownership history of IMMUNOCELLULAR THERAPEUTICS
ValueSharesWeighting
Q3 2016$7,0000.0%10,0000.0%0.00%
Q2 2016$7,0000.0%10,0000.0%0.00%
Q1 2016$7,000
+75.0%
10,0000.0%0.00%
Q4 2015$4,0000.0%10,0000.0%0.00%
Q3 2015$4,000
-42.9%
10,0000.0%0.00%
Q2 2015$7,0000.0%10,0000.0%0.00%
Q1 2015$7,0000.0%10,0000.0%0.00%
Q4 2014$7,000
-22.2%
10,0000.0%0.00%
Q3 2014$9,000
-18.2%
10,0000.0%0.00%
Q2 2014$11,000
-8.3%
10,0000.0%0.00%
Q1 2014$12,000
+33.3%
10,0000.0%0.00%
Q4 2013$9,000
-65.4%
10,0000.0%0.00%
Q3 2013$26,000
+36.8%
10,0000.0%0.00%
Q2 2013$19,00010,0000.00%
Other shareholders

There were no reported owners of IMMUNOCELLULAR THERAPEUTICS in Q2 2016.

NameSharesValueWeighting ↓
View complete list of IMMUNOCELLULAR THERAPEUTICS shareholders